Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 12.97% vs -23.86% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 73.66% vs -23.89% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 51.25% vs 64.44% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -100.00% vs -19.64% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Guilin Sanjin Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 12.97% vs -23.86% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -9.11% vs 22.38% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 73.66% vs -23.89% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -9.45% vs -4.42% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 51.25% vs 64.44% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -6.57% vs 0.72% in Jun 2024
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






